“vancomycin” Archives

Entry Author Date Location
Inhaled-Drug Maker Savara Buys European Biotech With Two Candidates 06/21/16 Texas
Austin Biotech Savara Nets $20M in Series C for Phase 3 Study 03/01/16 Texas
Accelerator, Gates Team Up in NY to Put $17M Into Rockefeller Startup 01/10/16 New York
With Crossover Cash, Seres Health Aims For Big Microbiome Milestones 12/02/14 Boston
Seres Makes Push for First Drug, and IPO, of Microbiome Era 07/16/14 Boston
East Coast Biotech Roundup: Moderna, Aileron, Seres, & More 11/22/13 Boston
Savara Enters the Proving Ground With Inhalable Antibiotic for CF 05/01/13 Texas
UCSD Business School’s Venture Fund Joins Texas Startup’s $16M Deal 03/20/13 San Diego
FDA Approves Optimer Antibiotic, Amylin Wins Legal Round Against Lilly, Investors Excited by Orexigen Move, & More San Diego Life Sciences News 06/02/11 San Diego
Optimer Passes Second Big Trial of Drug for Deadly Bacteria 02/04/10 San Diego
Optimer Sharpens Up Commercial Game Plan, After “C.Diff” Drug Success 12/05/08 San Diego
Isis Spinoff Ibis Biosciences, Looking at DNA of Infectious Bugs, Aims to Identify What They Are, Faster 10/27/08 San Diego
Optimer, Developer of Drug For “C. Diff” Bacteria, Awaits Pivotal Results 10/23/08 San Diego
Enanta Pharmaceuticals Starts Clinical Trial of Antibiotic for Drug Resistant Bacteria 09/15/08 Boston
Page 1 of 1